Exosome-transmitted p120-catenin suppresses hepatocellular carcinoma progression via STAT3 pathways.

Hepatocellular carcinoma (HCC) is a fatal disease with increasing morbidity and poor prognosis due to surgical recurrence and metastasis. Moreover, the molecular mechanism of HCC progression remains unclear. Although the role of p120-catenin (p120ctn) in liver cancer is well studied, the effects of secreted p120ctn transported by exosomes are less understood. Here, we show that p120ctn in exosomes secreted from liver cancer cells suppresses HCC cell proliferation and metastasis and expansion of liver cancer stem cells (CSCs). Mechanically, exosome p120ctn inhibits HCC cell progression via the STAT3 pathway, and the STAT3 inhibitor S3I-201 abolishes the observed effects on growth, metastasis, and self-renewal ability between exosome p120ctn-treated HCC cells and control cells. Taken together, we propose that p120ctn-containing exosomes derived from cancer cells inhibit the progression of liver cancer and may offer a new therapeutic strategy.

[1]  Y. Kong,et al.  Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma. , 2018, Journal of hepatology.

[2]  Ming Chen,et al.  Jinfu’an Decoction Inhibits Invasion and Metastasis in Human Lung Cancer Cells (H1650) via p120ctn-Mediated Induction and Kaiso , 2018, Medical science monitor : international medical journal of experimental and clinical research.

[3]  J. Gingold,et al.  Genomic Profiling and Metabolic Homeostasis in Primary Liver Cancers. , 2018, Trends in molecular medicine.

[4]  Hongyang Wang,et al.  Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer , 2018, Nature Communications.

[5]  W. Cong,et al.  Chronic inflammation‐elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance , 2017, Hepatology.

[6]  M. Washington,et al.  p120-Catenin is an obligate haploinsufficient tumor suppressor in intestinal neoplasia , 2017, The Journal of clinical investigation.

[7]  Z. Wang,et al.  Janus Gold Nanoplatform for Synergetic Chemoradiotherapy and Computed Tomography Imaging of Hepatocellular Carcinoma. , 2017, ACS nano.

[8]  H. Tilg,et al.  Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma , 2017, Gut.

[9]  Jin Ding,et al.  The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis , 2017, Gut.

[10]  D. Bikle,et al.  p120‐Catenin Is Required for Dietary Calcium Suppression of Oral Carcinogenesis in Mice , 2017, Journal of cellular physiology.

[11]  T. Han,et al.  Shp2 promotes liver cancer stem cell expansion by augmenting β‐catenin signaling and predicts chemotherapeutic response of patients , 2017, Hepatology.

[12]  Y. Ba,et al.  Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis , 2017, Nature Communications.

[13]  K. Zen,et al.  Shikonin Inhibits the Proliferation of Human Breast Cancer Cells by Reducing Tumor-Derived Exosomes , 2016, Molecules.

[14]  M. Amiji,et al.  Exosome mediated communication within the tumor microenvironment. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[15]  T. Han,et al.  PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients. , 2015, Journal of hepatology.

[16]  A. Baccarelli,et al.  Microvesicle-associated microRNA expression is altered upon particulate matter exposure in healthy workers and in A549 cells , 2014, Journal of applied toxicology : JAT.

[17]  Hong-Yang Wang,et al.  MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients. , 2013, Gastroenterology.

[18]  Shao-hong Huang,et al.  Epidermal Growth Factor Receptor-Containing Exosomes Induce Tumor-Specific Regulatory T Cells , 2013, Cancer investigation.

[19]  Michael Lock,et al.  Radiotherapy for liver metastases: a review of evidence. , 2012, International journal of radiation oncology, biology, physics.

[20]  C. Théry,et al.  Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation , 2012, Journal of extracellular vesicles.

[21]  Jing Li,et al.  Secreted monocytic miR-150 enhances targeted endothelial cell migration. , 2010, Molecular cell.

[22]  Jacopo Meldolesi,et al.  Shedding microvesicles: artefacts no more. , 2009, Trends in cell biology.

[23]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[24]  Xinmin Cao,et al.  Structure, function, and regulation of STAT proteins. , 2006, Molecular bioSystems.

[25]  Agnes B. Kane,et al.  Central Role of the Threonine Residue within the p+1 Loop of Receptor Tyrosine Kinase in STAT3 Constitutive Phosphorylation in Metastatic Cancer Cells , 2004, Molecular and Cellular Biology.

[26]  H. Spring,et al.  A novel cell-cell junction system: the cortex adhaerens mosaic of lens fiber cells , 2003, Journal of Cell Science.

[27]  Laurence Zitvogel,et al.  Exosomes: composition, biogenesis and function , 2002, Nature Reviews Immunology.

[28]  S. Akira,et al.  Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway , 1994, Cell.

[29]  G. Gores,et al.  Hepatocellular carcinoma , 2016, Nature Reviews Disease Primers.

[30]  C. Zhong,et al.  P120ctn may participate in epithelial-mesenchymal transition in OSCC. , 2016, Indian journal of cancer.

[31]  N. Copeland,et al.  The gene encoding p120cas, a novel catenin, localizes on human chromosome 11q11 (CTNND) and mouse chromosome 2 (Catns). , 1996, Genomics.